Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study

Akinci, M.; Algin, E.; Inal, A.; Odabas, H.; Berk, V.; Coskun, UĞUR; Uyeturk, U.; Isikdogan, A.; Aksoy, S.; Civelek, B.; Sevinc, A.; Buyukberber, S.

Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study

Akinci M. B., Algin E., Inal A., Odabas H., Berk V., Coskun U., ...Daha Fazla

JOURNAL OF BUON, cilt.18, sa.2, ss.314-320, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 2
Basım Tarihi: 2013
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.314-320
Gazi Üniversitesi Adresli: Evet

Özet

Purpose: Anthracyclines and taxanes are the most active agents in the adjuvant treatment of breast cancer (BC). They can be used simultaneously or sequentially. The optimal schedule and duration for their administration is unknown. We analyzed the efficacy of sequential adjuvant anthracycline and docetaxel administration in node positive BC patients.